The U.S. Ovarian Cancer Diagnostics Market is projected to grow from USD 1.53 Billion in 2025 to USD 2.28 Billion by 2035, while Europe is expected to expand from USD 1.38 Billion to USD 2.18 Billion, supported by increasing adoption of AI-powered imaging, biomarker testing, and precision oncology diagnostics. The U.S. Ovarian Cancer Diagnostics Market is projected to grow from USD 1.53 Billion in 2025 to USD 2.28 Billion by 2035, while Europe is expected to expand from USD 1.38 Billion to USD 2